On December 30, 2024, InnoScience (Suzhou) Technology Holding Co., Ltd. (2577.HK, InnoScience) successfully listed on the Main Board of the Hong Kong Stock Exchange (HKEx), raising a total of HKD1.4 billion. CBI is honored to participate in the due diligence work for this IPO Project.

InnoScience is a GaN power semiconductor manufacturer. The company adopted an Integrated Device Manufacturer (“IDM”) model that enables in-house control over the entire process from design, manufacturing, packaging, testing and sales of the finished products with a production base having a capacity of 12,500 wafers per month. The company had 406 patents and 387 patent applications in the world.

In this IPO project, CBI primarily assisted the sponsor team in conducting due diligence on the group company, its directors, senior management, shareholders, suppliers and customers. In addition to the basic information such as litigation, bankruptcy, winding-up and media records, CBI also assisted the sponsor team in conducting UBO check and Reputation Intelligence. The due diligence project globally covers 12 countries and regions, including China, Hong Kong, USA, Germany, Belgium and New Zealand, etc.